Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 115 articles:
HTML format



Single Articles


    May 2024
  1. ZHU J, Li X, Huang M, Zhu H, et al
    Application of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Acute Rectal Injury: A Multi-center, Randomized, Open-label, Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2024 May 3:S0360-3016(24)00611.
    PubMed     Abstract available


  2. COLSON-FEARON D, Han K, Roumeliotis MB, Viswanathan AN, et al
    Updated Trends in Cervical Cancer Brachytherapy Utilization and Disparities in the United States From 2004 to 2020.
    Int J Radiat Oncol Biol Phys. 2024;119:154-162.
    PubMed     Abstract available


    March 2024
  3. CHOW Z, Fabian D
    Cervical Cancer With Vaginal Recurrence and Prior Pelvic Radiation.
    Int J Radiat Oncol Biol Phys. 2024;118:886-887.
    PubMed    


  4. GEORGE J, Tuli S, Patel PP, Monare B, et al
    Delays in cervical cancer treatment initiation for patients living with or without HIV in Botswana: An observational cohort analysis (2015-2019).
    Int J Radiat Oncol Biol Phys. 2024 Mar 8:S0360-3016(24)00354.
    PubMed     Abstract available


  5. FIELDS EC, Erickson B, Hubbard A, Chino J, et al
    Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138-1142.
    Int J Radiat Oncol Biol Phys. 2024;118:869.
    PubMed    


  6. MEI X, Kok HP, Rodermond HM, van Bochove GGW, et al
    Radiosensitization by Hyperthermia Critically Depends on the Time Interval.
    Int J Radiat Oncol Biol Phys. 2024;118:817-828.
    PubMed     Abstract available


    February 2024
  7. KASSICK M, Taunk NK
    Pelvic Nodal Recurrence in Uterine Cancer: Novel Management and a Radiation Riddle.
    Int J Radiat Oncol Biol Phys. 2024;118:318.
    PubMed    


    December 2023
  8. HUMPHREY P, Dures E, Hoskin P, Cramp F, et al
    Patient experiences of brachytherapy for locally advanced cervical cancer: hearing the patient voice through qualitative interviews.
    Int J Radiat Oncol Biol Phys. 2023 Dec 26:S0360-3016(23)08253.
    PubMed     Abstract available


  9. MANTZ C
    Comments on "Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy".
    Int J Radiat Oncol Biol Phys. 2023;117:1143-1144.
    PubMed    


  10. FIELDS EC, Erickson B, Chino J, Small C, et al
    Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2023;117:1138-1142.
    PubMed    


    November 2023
  11. AKINFENWA CA, Allanson E, Ewongwo A, Lumley C, et al
    Mapping of radiation oncology and gynecologic oncology services available to treat the growing burden of cervical cancer in Africa.
    Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08043.
    PubMed     Abstract available


  12. CORBEAU A, Heemsbergen WD, Kuipers SC, Godart J, et al
    Predictive factors for toxicity after primary chemoradiation for locally advanced cervical cancer: a systematic review.
    Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08133.
    PubMed     Abstract available


  13. HAN K, Colson-Fearon D, Liu ZA, Viswanathan A, et al
    Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the U.S.: A Surveillance, Epidemiology, and End-Results Study.
    Int J Radiat Oncol Biol Phys. 2023 Nov 9:S0360-3016(23)08132.
    PubMed     Abstract available


    October 2023
  14. GHOSH DS, Gurram DL, Kumar DA, Mulye DG, et al
    Clinical implementation of 'plan of the day' strategy in definitive radiotherapy of cervical cancer: Online adaptation to address the challenge of organ filling reproducibility.
    Int J Radiat Oncol Biol Phys. 2023 Oct 8:S0360-3016(23)07956.
    PubMed     Abstract available


    September 2023
  15. CHO WK, Kim HS, Park W, Kim YS, et al
    The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07).
    Int J Radiat Oncol Biol Phys. 2023;117:154-163.
    PubMed     Abstract available


    August 2023
  16. LAVILLE A, Ka K, El-Ayachi R, Achkar S, et al
    Locoregional treatment in patients with metastatic cervical cancer: benefit of dose escalation strategies.
    Int J Radiat Oncol Biol Phys. 2023 Aug 14:S0360-3016(23)07744.
    PubMed     Abstract available


    July 2023
  17. KUMAR A, Gurram L, Nayak P, Mulye G, et al
    Correlation of haematological parameters with clinical outcomes in cervical cancer patients treated with radical radio (chemo) therapy - A retrospective study.
    Int J Radiat Oncol Biol Phys. 2023 Jul 26:S0360-3016(23)07677.
    PubMed     Abstract available


    June 2023
  18. LIN LL, Msadabwe SC, Chiao E
    Improving Access to Radiation Therapy Globally To Meet World Health Organization Goals To Eliminate Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2023;116:459-462.
    PubMed    


  19. LIN LL, Ndlovu N, Lowenstein J, Wirth M, et al
    Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan Africa.
    Int J Radiat Oncol Biol Phys. 2023;116:439-447.
    PubMed     Abstract available


    April 2023
  20. MARAR M, Niedermayr T, Kidd E
    Developing next generation 3D-printing for cervical cancer hybrid brachytherapy: a guided interstitial technique enabling improved flexibility, dosimetry, and efficiency.
    Int J Radiat Oncol Biol Phys. 2023 Apr 12:S0360-3016(23)00364.
    PubMed     Abstract available


  21. LI B, Hirata E, Trejo JM, Garcia B, et al
    Exploring the Cost of Radiation Therapy Delivery for Locally Advanced Cervical Cancer in a Public and a Private Center in Latin America Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2023;115:1205-1216.
    PubMed    


    March 2023
  22. KOK HP, Herrera TD, Crezee J
    The Relevance of High Temperatures and Short Time Intervals Between Radiation Therapy and Hyperthermia: Insights in Terms of Predicted Equivalent Enhanced Radiation Dose.
    Int J Radiat Oncol Biol Phys. 2023;115:994-1003.
    PubMed     Abstract available


    February 2023
  23. SAMMOURI J, Wong MC, Lynn EJ, El Alam MB, et al
    Serial genotyping of the human papillomavirus in cervical cancer: an insight into virome dynamics during chemoradiation therapy.
    Int J Radiat Oncol Biol Phys. 2023 Feb 16:S0360-3016(23)00163.
    PubMed     Abstract available


  24. CORRADINI S, Seidensticker M
    "New" Kid on the Block: Interstitial Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2023;115:277-279.
    PubMed    


  25. HARKENRIDER M, Fields E, Chopra S, Damast S, et al
    Recent Key Studies in Cancers of the Uterine Corpus and Cervix: New Updates in Immunotherapy, the Microbiome, Bone Density, Quantifying Lymphovascular Invasion, and Hypofractionated Pelvic Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023;115:269-275.
    PubMed    


    January 2023
  26. VITTRUP AS, Kirchheiner K, Potter R, Fokdal LU, et al
    Overall severe morbidity after chemo-radiotherapy and MRI guided adaptive brachytherapy in locally advanced cervical cancer: results from the EMBRACE-I study.
    Int J Radiat Oncol Biol Phys. 2023 Jan 11:S0360-3016(23)00007.
    PubMed     Abstract available


    November 2022
  27. JIANG P, Deng X, Qu A, Jiang W, et al
    Image-guidance volume modulated arc radiotherapy concurrently with Nab-paclitaxel plus cisplatin for patients with locally advanced cervical cancer: a single-arm dose escalation trial.
    Int J Radiat Oncol Biol Phys. 2022 Nov 16:S0360-3016(22)03522.
    PubMed     Abstract available


    October 2022
  28. YODER AK, Dong E, Yu X, Echeverria A, et al
    Impact of Quality of Life on Radiation Adherence for Cervical Cancer Patients in an Urban Safety Net Health System.
    Int J Radiat Oncol Biol Phys. 2022 Oct 10. pii: S0360-3016(22)03439.
    PubMed     Abstract available


    September 2022
  29. KAMRAVA M, Leung E, Bachand F, Beriwal S, et al
    GEC-ESTRO (ACROP) - ABS - CBG Consensus Brachytherapy Target Definition Guidelines for Recurrent Endometrial and Cervical Tumors in the Vagina.
    Int J Radiat Oncol Biol Phys. 2022 Sep 30. pii: S0360-3016(22)03396.
    PubMed     Abstract available


  30. MARAR M, Simiele E, Niedermayr T, Kidd EA, et al
    Applying 3D-Printed Templates in High-Dose-Rate Brachytherapy for Cervix Cancer: Simplified Needle Insertion for Optimized Dosimetry.
    Int J Radiat Oncol Biol Phys. 2022;114:111-119.
    PubMed     Abstract available


    August 2022
  31. MULANI J, Jain J, Gupta A, Swamidas J, et al
    Dose Accumulation for Multicourse Gynecological Reirradiation: A Methodological Narrative and Clinical Examples.
    Int J Radiat Oncol Biol Phys. 2022;113:1085-1090.
    PubMed     Abstract available


    July 2022
  32. BARRY P, Beriwal S
    Combination of Knife and Rays with MRI-Guided Ablative Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2022;113:717-718.
    PubMed    


  33. CHOPRA S, Kalra B, Mulani J, Jain J, et al
    Salvage (re) radiation in oligometastatic and oligorecurrent cervical cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jul 15. pii: S0360-3016(22)00722.
    PubMed     Abstract available


    June 2022
  34. GOUVEIA AG, Viani GA, Bratti VF, Pavoni JF, et al
    System-level capacity of high dose rate (HDR) brachytherapy for management of cervical cancer in an upper middle-income country: a case study from Brazil.
    Int J Radiat Oncol Biol Phys. 2022 Jun 29. pii: S0360-3016(22)00624.
    PubMed     Abstract available


  35. RICH BJ, Montoya C, Jin WH, Spieler BO, et al
    Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jun 4. pii: S0360-3016(22)00545.
    PubMed     Abstract available


    March 2022
  36. KIDD E, Harkenrider M, Damast S, Fields E, et al
    Improving Radiation Therapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2022;112:841-848.
    PubMed    


    February 2022
  37. MITTAL P, Chopra S, Charnalia M, Dora T, et al
    Patterns of relapse after adjuvant (chemo)radiation for cervical cancer in a phase III clinical trial (PARCER): an evaluation of updated NRG Oncology /RTOG target delineation guidelines.
    Int J Radiat Oncol Biol Phys. 2022 Feb 11. pii: S0360-3016(22)00153.
    PubMed     Abstract available


  38. LINDEGAARD JC, Petric P, Schmid MP, Nesvacil N, et al
    Prognostic implications of uterine cervical cancer regression during chemoradiation evaluated by the T-score in the multicenter XXX study.
    Int J Radiat Oncol Biol Phys. 2022 Feb 11. pii: S0360-3016(22)00151.
    PubMed     Abstract available


  39. DAMAST S, Chino J
    Secondary Prevention, Not Secondary Importance: Embracing Survivorship Concerns and HRT After Cervical Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;112:414-416.
    PubMed    


    January 2022
  40. WILLIAMSON CW, Sirak I, Xu R, Portelance L, et al
    Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III Trial.
    Int J Radiat Oncol Biol Phys. 2022;112:169-178.
    PubMed     Abstract available


    November 2021
  41. SMET S, Spampinato S, Potter R, Jurgenliemk-Schulz IM, et al
    Risk factors for late persistent fatigue after chemoradiotherapy in locally advanced cervical cancer: an analysis from the EMBRACE-I study.
    Int J Radiat Oncol Biol Phys. 2021 Nov 25. pii: S0360-3016(21)03220.
    PubMed     Abstract available


  42. WANG X, Ouyang G, Chen Z, Fu L, et al
    Automatic Contouring of the Clinical Target Volume (CTV) for Cervical Cancer Adjuvant Radiotherapy Using Deep Learning Algorithm.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  43. KAWAHARA D, Nishibuchi I, Kawamura M, Yoshida T, et al
    Radiomic Analysis for Pretreatment Prediction of Recurrence after Radiotherapy in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  44. ZHOU Z, Zhang F, Hu K
    High Dose Radiotherapy Combined With TGF-beta Blocking Alleviate Cervical Cancer Cell-Suppressed Dendritic Cell Homing Through PGE2 Pathway.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  45. YANG H, Zhang Y, Liu C, Zhao L, et al
    Combined Modality of Bevacizumab With Radical Radiotherapy and Chemotherapy in the Treatment of Refractory Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  46. WU J, Lakomy DS, Fellman B, Salcedo MP, et al
    Bone Mineral Density Changes Within and Outside of RT Fields Used to Treat Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  47. WILLIAMSON CW, Kotha NV, Morris K, Simoes-Torigoe R, et al
    Radiation-Induced Vaginal Stenosis in Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  48. WEIL C, Parsons MW, Chipman J, Kraus RD, et al
    Secondary Malignancy Risk in Cervical Cancer Survivors After 40 Years of Follow-Up Stratified by Treatment Modality and Radiation Technique.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  49. WANG D, Hu K, Zhang F
    Impact of Body Mass Index and Abdominal Subcutaneous Fat Thickness of Setup Errors in Postoperative Cervical Cancer Patients Underwent Daily Image-Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  50. WEI C, Franco II, Orio PF 3rd, Mak RH, et al
    Comparison of Cost vs. Reimbursement for Definitive Radiotherapy in Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  51. THOMAS RJ, Provenzano D, Goyal S, Loew M, et al
    Trends in Guideline-Adherent Chemoradiation Therapy for Locally Advanced Cervical Cancer Before and After the Affordable Care Act.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  52. SHI V, Huang Y, Grigsby PW, Markovina S, et al
    Serum SCCA as an Early Indicator of Recurrence in Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  53. RAHIMY E, Von Eyben R, Lewis J, Hristov DH, et al
    Dosimetric and Metabolic Parameters Predictive of Hematologic Toxicity in Cervical Cancer Patients Undergoing Definitive Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  54. PINTO PJJ, Favareto SL, Souza CFPM, Baiocchi G, et al
    Do Radiotherapy Planning Factors Influence Para-Aortic Recurrence in IIIC1 Cervical Cancer Patients?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  55. PACHIGOLLA SL, Markovina S, Lin AJ, Schwarz JK, et al
    Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Locally Advanced Cervical Cancer Not Amenable to Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  56. ONAL C, Guler OC, Reyhan M, Yapar AF, et al
    Long-Term Outcomes of Cervical Cancer Patients With Complete Metabolic Response After Definitive Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  57. PACHIGOLLA SL, Massad LS, Thaker P, Mutch D, et al
    A Nomogram Predicting Early Cervical Cancer Distant Recurrence.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  58. NISHIBUCHI I, Kawahara D, Kawamura M, Kubo K, et al
    A Prediction Model for Para-Aortic Lymph Node Metastasis in Cervical Cancer by Radiomics Analysis Using Pre-Treatment MRI Images of the Primary Tumor.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  59. LIU C, Li A, Wang C, Zou W, et al
    Intratumor Microbiome and Its Correction With Tumor Response After Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  60. LI F, Li J, Yin S, Mei F, et al
    A Phase III Prospective Randomized Controlled Clinical Trial for the Efficacy and Safety of Neoadjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (Lump >/=4 cm).
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  61. LI J, Mao W, Li F, Ran L, et al
    A Phase II, Single-Arm, Prospective Clinical Trial for the Efficacy and Safety of Apatinib Combined With Capecitabine in Therapy for Recurrent/Metastatic and Persistent Cervical Cancer After Radiochemotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  62. KOTHA NV, Williamson CW, McHale M, Mell LK, et al
    Ineligible and Incomplete Cisplatin Regimens in Chemoradiation Treatment for Patients With Locally Advanced Cervical Cancer: A Population for Survival Improvement.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  63. LEE TH, Kim IA, Kim JS Jr, Song C, et al
    Stereotactic Ablative Body Radiotherapy Boost for Cervical Cancer When Brachytherapy Boost is Not Feasible.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  64. KIM KH, Chang JS, Kim YB
    A Novel Gene Signature Associated With Poor Response to Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  65. KOERNER SA, Baig T, Kim H, Rodriguez-Lopez JL, et al
    Can We Avoid Ureters as Organs at Risk With MRI-Based Brachytherapy for Cervical Cancer? A Dosimetric Feasibility Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  66. GJYSHI O, Grippin A, Boyce-Fappiano D, Jhingran A, et al
    Circulating and Tumor-Associated Neutrophils Function as a Powerful Biomarker for Response to Chemoradiation in Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  67. HOLLIS ES, Ruebush E, Davies E, Paraghamian S, et al
    Smoking Cessation Interventions During Chemoradiotherapy for Locally Advanced Cervical Cancer: A Missed Opportunity?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  68. GEORGE J, Tuli S, Monare B, Lichter K, et al
    Stage and Outcomes of Cervical Cancer With or Without HIV Infection in Botswana 2013-2020.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  69. FREIJE S, Steele EM, Robertson SE, Ishaq O Jr, et al
    Medicaid Expansion Through the Affordable Care Act and Receipt of Guideline Recommended Brachytherapy for Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  70. DING S, Liu H, Wang B, Li Y, et al
    Inter- and Intrafraction Bladder and Rectum Motion in Patients With Cervical Cancer Under MR-Guided Radiotherapy on a 1.5T MR-Linac.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  71. COUSINS DF, Sanders J, Muller DA, Ward KA, et al
    Disease Characteristics and Patterns of Failure by Histologic Type for Patients Treated With Definitive Radiation for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  72. D'CUNHA P, Gonzalez Y, Nwachukwu CR, Hrycushko BA, et al
    Change in Image-Guided Planning Strategies Over Time Impacts Global Outcomes for Intracavitary Cervical Cancer Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  73. AZGHADI S, Beagen PL, Ahmed A, Valicenti RK, et al
    Toxicity Related Patients Factors and Bevasizumab Use in Patients With Locally Advanced Cervical Cancer Treated With Definitive Chemoradiation and HDR Brachytherapy Boost.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  74. CHEN Y, Sun C, Li Q, Tang H, et al
    The Effect of Bulk Electron Density on the Accuracy of Treatment Planning for Postoperative Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  75. CHOQUE R, Aviles L, Rosas M, Suarez R, et al
    PET CT Based Stereotactic Body Radiosurgery (SBRT) in Non-Metastatic Cervical Cancer. The First Bolivian Experience.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  76. KOTHA NV, Williamson CW, Mell LK, Murphy JD, et al
    Racial Disparities in Time to Start of Definitive Radiation Treatment for Patients With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  77. AZGHADI S, Beagen PL, Ahmed A, Valicenti RK, et al
    Disparities and Health Access in Brachytherapy Boost Administration in Woman With Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  78. URBAN R, Wong J, Lim P, Zhang S, et al
    Cervical Cancer Patient Reported Gastrointestinal Outcomes: Intensity/Volumetric Modulated vs. 3D Conformal Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  79. TARIQ M, Denniston KA
    EQD2 Dose Accumulation Based on Deformable Image Registration of HR-CTV, Bladder, Rectum and Bowel for Combined External-Beam Radiotherapy and Brachytherapy for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  80. YEN A, Morgan HE, Wang K, Albuquerque KV, et al
    Interpretable Machine Learning Model Supported by Parallel Ensemble Learning to Predict Local Recurrence for Patients with Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  81. REIJTENBAGH DMW, Godart J, De Leeuw A, Seppenwoolde Y, et al
    A Machine-Learning Based Method for Inter-Institutional QA of MR-Based Brachytherapy Treatment Planning in Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  82. LIU C, Wang C, Hu X, Zou W, et al
    Dissecting Concurrent Chemoradiotherapy-Induced Landscape Alteration of Tumor Microenvironment in Locally Advanced Cervical Cancer at Single Cell Resolution.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  83. WANG W, Hu K, Zhang F
    Prophylactic Extended-Field Irradiation vs. Pelvic Irradiation in Cervical Cancer Patients With 2018 FIGO IIIC1 Diseases.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  84. HAN K, Fyles TW, Shek T, Croke JM, et al
    Chemoradiation With or Without Metformin in Locally Advanced Cervical Cancer: Phase II Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  85. ZHANG Y, Liu C, Yang H, Shi M, et al
    Weekly Cisplatin vs. Triweekly Docetaxel Plus Cisplatin With Concurrent Chemoradiation in Post-Operative Treatment for Cervical Cancer With High-Risk Pathological Factors: A Randomized Controlled Phase III Trial From a Single Institution.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  86. NDUMBALO J, Muya S, Nyagabona SK, Yusuph S, et al
    Continuing Education Needs Identified During the Initial Experience of Delivering 3D Conformal Radiotherapy for Cervical Cancer Patients in Tanzania.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  87. YANEY A, Mladkova N, Quick AM
    Clinical and Genomic Determinants of Survival in Ugandan Women With Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  88. BHATIA R, Ramogola-Masire D, Friebel-Klingner T, Monare B, et al
    Cervical Cancer Screening in Botswana: An Urgent Call for Guideline Change.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


    October 2021
  89. SPAMPINATO S, Jensen NBK, Potter R, Fokdal LU, et al
    Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer: lessons learned from EMBRACE-I and implications for the future.
    Int J Radiat Oncol Biol Phys. 2021 Oct 19. pii: S0360-3016(21)02915.
    PubMed     Abstract available


  90. DAMAST S, Fields E, Kidd E, Harkenrider M, et al
    Reports From Four International Clinical Trials for Cancers of the Cervix, Uterus and Vulva, and a New Guideline for Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111:299-306.
    PubMed    


    August 2021
  91. KIRCHHEINER K, Smet S, Jurgenliemk-Schulz IM, Haie-Meder C, et al
    Impact of vaginal symptoms and hormonal replacement therapy on sexual outcomes in locally advanced cervical cancer patients after definitive chemoradiotherapy - results from the EMBRACE-I study.
    Int J Radiat Oncol Biol Phys. 2021 Aug 31. pii: S0360-3016(21)02729.
    PubMed     Abstract available


    June 2021
  92. KIM H, Lee YC, Benedict SH, Dyer B, et al
    Dose summation strategies for external beam radiation therapy and brachytherapy in gynecologic malignancy: a review from the NRG Oncology and NCTN medical physics subcommittees.
    Int J Radiat Oncol Biol Phys. 2021 Jun 17. pii: S0360-3016(21)00737.
    PubMed     Abstract available


  93. MAHANTSHETTY U, Gurram L, Bushra S, Ghadi Y, et al
    Single application multi-fractionated image guided adaptive High Dose Rate Brachytherapy for Cervical Cancer- Dosimetric & Clinical Outcomes.
    Int J Radiat Oncol Biol Phys. 2021 Jun 16. pii: S0360-3016(21)00732.
    PubMed     Abstract available


    April 2021
  94. STURDZA AE, Poetter R, Kossmeier M, Kirchheiner K, et al
    Nomogram predicting overall survival in locally advanced cervical cancer patients treated by radio-chemotherapy including image guided brachytherapy: a Retro-EMBRACE study.
    Int J Radiat Oncol Biol Phys. 2021 Apr 28. pii: S0360-3016(21)00404.
    PubMed     Abstract available


    March 2021
  95. CHAUDARY N, Hill RP, Stulik L, Milosevic M, et al
    The oral CXCR4 inhibitor X4-136 improves tumor control and reduces toxicity in cervical cancer treated with radiotherapy and concurrent chemotherapy.
    Int J Radiat Oncol Biol Phys. 2021 Mar 23. pii: S0360-3016(21)00291.
    PubMed     Abstract available


  96. LI R, Liu Y, Yin R, Yin L, et al
    The Dynamic alternation of Local and Systemic Tumor Immune Microenvironment during Concurrent Chemoradiotherapy of Cervical Cancer: A Prospective Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2021 Mar 10. pii: S0360-3016(21)00243.
    PubMed     Abstract available


  97. K JENSEN NB, Potter R, Spampinato S, Fokdal LU, et al
    Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study.
    Int J Radiat Oncol Biol Phys. 2021;109:688-700.
    PubMed     Abstract available


    February 2021
  98. DATTA NR, Stutz E, Gomez S, Bodis S, et al
    In Reply to Roussakow.
    Int J Radiat Oncol Biol Phys. 2021;109:642-644.
    PubMed    


  99. ROUSSAKOW S
    In Regard to Datta et al.
    Int J Radiat Oncol Biol Phys. 2021;109:641-642.
    PubMed    


    December 2020
  100. RAUT A, Chopra S, Mittal P, Patil G, et al
    FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2020;108:1248-1256.
    PubMed     Abstract available


  101. YUSUFALY T, Miller A, Medina-Palomo A, Williamson CW, et al
    A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial.
    Int J Radiat Oncol Biol Phys. 2020;108:1240-1247.
    PubMed     Abstract available


    November 2020
  102. FEDERICO C, Sun J, Muz B, Alhallak K, et al
    Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side-Effect Profile.
    Int J Radiat Oncol Biol Phys. 2020 Nov 27. pii: S0360-3016(20)34592.
    PubMed     Abstract available


  103. BERGER T, Godart J, Jagt T, Vittrup AS, et al
    DOSIMETRIC IMPACT OF INTRA-FRACTION MOTION IN ONLINE-ADAPTIVE IMPT FOR CERVICAL CANCER.
    Int J Radiat Oncol Biol Phys. 2020 Nov 20. pii: S0360-3016(20)34559.
    PubMed     Abstract available


  104. ARYA R, Golden DW
    A Curious Case of Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:846-847.
    PubMed    


  105. DYER BA, Mayadev JS
    Restage and Chemoradiation.
    Int J Radiat Oncol Biol Phys. 2020;108:849-850.
    PubMed    


  106. SON CH, Hasan Y
    A Parametrial Problem.
    Int J Radiat Oncol Biol Phys. 2020;108:849.
    PubMed    


  107. SINGER L, Lee LJ
    50 Gray is Not Enough.
    Int J Radiat Oncol Biol Phys. 2020;108:848-849.
    PubMed    


  108. CHINO J, Damast S, Kidd E, Harkenrider M, et al
    Radiation for Cancers of the Uterine Corpus and Cervix: Incremental Steps, and Glimmers of the Future.
    Int J Radiat Oncol Biol Phys. 2020;108:839-845.
    PubMed    


  109. RIGAUD B, Anderson BM, Yu ZH, Gobeli M, et al
    Automatic segmentation using deep learning to enable online dose optimization during adaptive radiotherapy of cervical cancer.
    Int J Radiat Oncol Biol Phys. 2020 Nov 9. pii: S0360-3016(20)34484.
    PubMed     Abstract available


  110. MAO X, Pineau J, Keyes R, Enger SA, et al
    RapidBrachyDL: Rapid Radiation Dose Calculations in Brachytherapy Via Deep Learning.
    Int J Radiat Oncol Biol Phys. 2020;108:802-812.
    PubMed     Abstract available


    October 2020
  111. HARARI PM, Lambert PF
    Life Beyond COVID: Pay Attention to Viruses.
    Int J Radiat Oncol Biol Phys. 2020;108:348-350.
    PubMed    


    September 2020
  112. DYER BA, Feng CH, Eskander R, Sharabi AB, et al
    Current Status of Clinical Trials for Cervical and Uterine Cancer Using Immunotherapy Combined with Radiation.
    Int J Radiat Oncol Biol Phys. 2020 Sep 14. pii: S0360-3016(20)34287.
    PubMed     Abstract available


    July 2020
  113. WANG Y, Chen H
    In Reply to Ghadjar et al.
    Int J Radiat Oncol Biol Phys. 2020;107:856.
    PubMed    


  114. GHADJAR P, Beck M, Zschaeck S, Wust P, et al
    In Regard to Wang et al.
    Int J Radiat Oncol Biol Phys. 2020;107:855.
    PubMed    


    April 2020
  115. MELL LK, Xu R, Yashar CM, McHale MT, et al
    Phase 1 Trial of Concurrent Gemcitabine and Cisplatin with Image-Guided Intensity Modulated Radiation Therapy for Locoregionally Advanced Cervical Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 Apr 22. pii: S0360-3016(20)31037.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.